137 related articles for article (PubMed ID: 38330765)
1. Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival.
Pire A; Hirsch TZ; Morcrette G; Imbeaud S; Gupta B; Pilet J; Cornet M; Fabre M; Guettier C; Branchereau S; Brugières L; Guerin F; Laithier V; Coze C; Nagae G; Hiyama E; Laurent-Puig P; Rebouissou S; Sarnacki S; Chardot C; Capito C; Faure-Conter C; Aerts I; Taque S; Fresneau B; Zucman-Rossi J
Eur J Cancer; 2024 Mar; 200():113583. PubMed ID: 38330765
[TBL] [Abstract][Full Text] [Related]
2. Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer.
Hirsch TZ; Pilet J; Morcrette G; Roehrig A; Monteiro BJE; Molina L; Bayard Q; Trépo E; Meunier L; Caruso S; Renault V; Deleuze JF; Fresneau B; Chardot C; Gonzales E; Jacquemin E; Guerin F; Fabre M; Aerts I; Taque S; Laithier V; Branchereau S; Guettier C; Brugières L; Rebouissou S; Letouzé E; Zucman-Rossi J
Cancer Discov; 2021 Oct; 11(10):2524-2543. PubMed ID: 33893148
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
Carrillo-Reixach J; Torrens L; Simon-Coma M; Royo L; Domingo-Sàbat M; Abril-Fornaguera J; Akers N; Sala M; Ragull S; Arnal M; Villalmanzo N; Cairo S; Villanueva A; Kappler R; Garrido M; Guerra L; Sábado C; Guillén G; Mallo M; Piñeyro D; Vázquez-Vitali M; Kuchuk O; Mateos ME; Ramírez G; Santamaría ML; Mozo Y; Soriano A; Grotzer M; Branchereau S; de Andoin NG; López-Ibor B; López-Almaraz R; Salinas JA; Torres B; Hernández F; Uriz JJ; Fabre M; Blanco J; Paris C; Bajčiová V; Laureys G; Masnou H; Clos A; Belendez C; Guettier C; Sumoy L; Planas R; Jordà M; Nonell L; Czauderna P; Morland B; Sia D; Losic B; Buendia MA; Sarrias MR; Llovet JM; Armengol C
J Hepatol; 2020 Aug; 73(2):328-341. PubMed ID: 32240714
[TBL] [Abstract][Full Text] [Related]
4. The genomic landscape of hepatoblastoma and their progenies with HCC-like features.
Eichenmüller M; Trippel F; Kreuder M; Beck A; Schwarzmayr T; Häberle B; Cairo S; Leuschner I; von Schweinitz D; Strom TM; Kappler R
J Hepatol; 2014 Dec; 61(6):1312-20. PubMed ID: 25135868
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
[TBL] [Abstract][Full Text] [Related]
6. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
Sunil BJ; Palaniappan R; Venkitaraman B; Ranganathan R
J Gastrointest Cancer; 2018 Dec; 49(4):493-496. PubMed ID: 28963691
[TBL] [Abstract][Full Text] [Related]
7. Analysis of factors related to recurrence of paediatric hepatoblastoma - a single Centre retrospective study.
Yang W; Chen Y; Huang Y; Wang H
BMC Pediatr; 2019 Dec; 19(1):485. PubMed ID: 31822277
[TBL] [Abstract][Full Text] [Related]
8. Novel Advances in Understanding of Molecular Pathogenesis of Hepatoblastoma: A Wnt/β-Catenin Perspective.
Bell D; Ranganathan S; Tao J; Monga SP
Gene Expr; 2017 Feb; 17(2):141-154. PubMed ID: 27938502
[TBL] [Abstract][Full Text] [Related]
9. General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study.
Lee H; El Jabbour T; Ainechi S; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon SH; Ali SM; Schrock A; Fabrizio D; Frampton G; Nazeer T; Miller VA; Stephens PJ; Ross JS
Hum Pathol; 2017 Dec; 70():84-91. PubMed ID: 29079173
[TBL] [Abstract][Full Text] [Related]
10. Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations.
Curia MC; Zuckermann M; De Lellis L; Catalano T; Lattanzio R; Aceto G; Veschi S; Cama A; Otte JB; Piantelli M; Mariani-Costantini R; Cetta F; Battista P
Mod Pathol; 2008 Jan; 21(1):7-14. PubMed ID: 17962810
[TBL] [Abstract][Full Text] [Related]
11. Independent Assessment of the Children's Hepatic Tumors International Collaboration Risk Stratification for Hepatoblastoma and the Association of Tumor Histological Characteristics With Prognosis.
Zhou S; Malvar J; Chi YY; Stein J; Wang L; Genyk Y; Sposto R; Mascarenhas L
JAMA Netw Open; 2022 Feb; 5(2):e2148013. PubMed ID: 35147687
[TBL] [Abstract][Full Text] [Related]
12. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
[TBL] [Abstract][Full Text] [Related]
13. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of molecular genetic alterations in hepatoblastoma.
von Schweinitz D; Kraus JA; Albrecht S; Koch A; Fuchs J; Pietsch T
Med Pediatr Oncol; 2002 Feb; 38(2):104-8. PubMed ID: 11813174
[TBL] [Abstract][Full Text] [Related]
15. Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex.
Jia D; Dong R; Jing Y; Xu D; Wang Q; Chen L; Li Q; Huang Y; Zhang Y; Zhang Z; Liu L; Zheng S; Xia Q; Wang H; Dong K; He X
Hepatology; 2014 Nov; 60(5):1686-96. PubMed ID: 24912477
[TBL] [Abstract][Full Text] [Related]
16. Mutant
Crippa S; Ancey PB; Vazquez J; Angelino P; Rougemont AL; Guettier C; Zoete V; Delorenzi M; Michielin O; Meylan E
EMBO Mol Med; 2017 Nov; 9(11):1589-1604. PubMed ID: 28923827
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of beta-catenin in hepatoblastoma and its clinical significance.
Archana B; D'Cruze L; Nazneen S; Thanka J; Scott JX
J Cancer Res Ther; 2022; 18(3):677-680. PubMed ID: 35900540
[TBL] [Abstract][Full Text] [Related]
18. β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.
Zhang W; Meyfeldt J; Wang H; Kulkarni S; Lu J; Mandel JA; Marburger B; Liu Y; Gorka JE; Ranganathan S; Prochownik EV
J Biol Chem; 2019 Nov; 294(46):17524-17542. PubMed ID: 31597698
[TBL] [Abstract][Full Text] [Related]
19. Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma.
Park WS; Oh RR; Park JY; Kim PJ; Shin MS; Lee JH; Kim HS; Lee SH; Kim SY; Park YG; An WG; Kim HS; Jang JJ; Yoo NJ; Lee JY
J Pathol; 2001 Apr; 193(4):483-90. PubMed ID: 11276007
[TBL] [Abstract][Full Text] [Related]
20. Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma.
Pilet J; Hirsch TZ; Gupta B; Roehrig A; Morcrette G; Pire A; Letouzé E; Fresneau B; Taque S; Brugières L; Branchereau S; Chardot C; Aerts I; Sarnacki S; Fabre M; Guettier C; Rebouissou S; Zucman-Rossi J
Nat Commun; 2023 Nov; 14(1):7122. PubMed ID: 37932266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
